Neurogene
NGNE
NGNE
43 hedge funds and large institutions have $300M invested in Neurogene in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.26% less ownership
Funds ownership: 4.77% → 4.51% (-0.26%)
4% less capital invested
Capital invested by funds: $314M → $300M (-$13.8M)
93% less call options, than puts
Call options by funds: $31K | Put options by funds: $427K
Holders
43
Holding in Top 10
1
Calls
$31K
Puts
$427K
Top Buyers
| 1 | +$3.55M | |
| 2 | +$1.42M | |
| 3 | +$1.13M | |
| 4 |
BlackRock
New York
|
+$352K |
| 5 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$298K |
Top Sellers
| 1 | -$19.6M | |
| 2 | -$3.02M | |
| 3 | -$1.28M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$704K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$321K |